These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 24800261)

  • 1. The dual role of HLA-G in cancer.
    Rouas-Freiss N; Moreau P; LeMaoult J; Carosella ED
    J Immunol Res; 2014; 2014():359748. PubMed ID: 24800261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.
    Wu D; Kuiaste I; Moreau P; Carosella E; Yotnda P
    Oncotarget; 2015 Nov; 6(35):37385-97. PubMed ID: 26460949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease.
    Martín-Villa JM; Vaquero-Yuste C; Molina-Alejandre M; Juarez I; Suárez-Trujillo F; López-Nares A; Palacio-Gruber J; Barrera-Gutiérrez L; Fernández-Cruz E; Rodríguez-Sainz C; Arnaiz-Villena A
    Front Immunol; 2022; 13():796054. PubMed ID: 35154112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunosuppressive molecule HLA-G and its clinical implications.
    González A; Rebmann V; LeMaoult J; Horn PA; Carosella ED; Alegre E
    Crit Rev Clin Lab Sci; 2012; 49(3):63-84. PubMed ID: 22537084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-G as a tolerogenic molecule in transplantation and pregnancy.
    Rebmann V; da Silva Nardi F; Wagner B; Horn PA
    J Immunol Res; 2014; 2014():297073. PubMed ID: 25143957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex bead-based immunoassay for the free soluble forms of the HLA-G receptors, ILT2 and ILT4.
    Wu CL; Svendsen SG; Riviere A; Desgrandchamps F; Carosella ED; LeMaoult J
    Hum Immunol; 2016 Sep; 77(9):720-6. PubMed ID: 26874236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-G and humanized mouse models as a novel therapeutic approach in transplantation.
    Ajith A; Portik-Dobos V; Horuzsko DD; Kapoor R; Mulloy LL; Horuzsko A
    Hum Immunol; 2020 Apr; 81(4):178-185. PubMed ID: 32093884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of soluble HLA-G and HLA-G receptors in patients with hematological malignancies after allogeneic stem cell transplantation.
    Biedroń M; Rybka J; Wróbel T; Prajs I; Poręba R; Kuliczkowski K
    Med Oncol; 2015 Aug; 32(8):219. PubMed ID: 26187179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-G: A New Immune Checkpoint in Cancer?
    Krijgsman D; Roelands J; Hendrickx W; Bedognetti D; Kuppen PJK
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-G regulators in cancer medicine: an outline of key requirements.
    Zidi I; Ben Amor N
    Tumour Biol; 2011 Dec; 32(6):1071-86. PubMed ID: 21792710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
    Attia JVD; Dessens CE; van de Water R; Houvast RD; Kuppen PJK; Krijgsman D
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
    Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance.
    Loumagne L; Baudhuin J; Favier B; Montespan F; Carosella ED; Rouas-Freiss N
    Int J Cancer; 2014 Nov; 135(9):2107-17. PubMed ID: 24623585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytometry-based analysis of HLA-G functions according to ILT2 expression.
    Jacquier A; Dumont C; Carosella ED; Rouas-Freiss N; LeMaoult J
    Hum Immunol; 2020 Apr; 81(4):168-177. PubMed ID: 32081570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma.
    García M; Palma MB; Verine J; Miriuka S; Inda AM; Errecalde AL; Desgrandchamps F; Carosella ED; Tronik-Le Roux D
    BMC Cancer; 2020 Jul; 20(1):624. PubMed ID: 32620162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction.
    Naji A; Menier C; Maki G; Carosella ED; Rouas-Freiss N
    Leukemia; 2012 Aug; 26(8):1889-92. PubMed ID: 22441169
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of HLA-G in tumors and upon COVID-19 infection.
    Seliger B
    Hum Immunol; 2024 May; 85(3):110792. PubMed ID: 38555250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses.
    Naji A; Menier C; Morandi F; Agaugué S; Maki G; Ferretti E; Bruel S; Pistoia V; Carosella ED; Rouas-Freiss N
    J Immunol; 2014 Feb; 192(4):1536-46. PubMed ID: 24453251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
    Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
    Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-G and HLA-E in patients with juvenile idiopathic arthritis.
    Prigione I; Penco F; Martini A; Gattorno M; Pistoia V; Morandi F
    Rheumatology (Oxford); 2011 May; 50(5):966-72. PubMed ID: 21186170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.